InflaRx
$4.919876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.02 (+0.42%) Today
+$0.08 (+1.66%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell InflaRx and other stocks, options, ETFs, and crypto commission-free!
About IFRX
InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Read More Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Employees
45
Headquarters
Jena, Thueringen
Founded
2007
Market Cap
126.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
373.56K
High Today
$5.02
Low Today
$4.76
Open Price
$4.88
Volume
303.05K
52 Week High
$9.70
52 Week Low
$2.17
Collections
Analyst Ratings
25%
of 8 ratings
Buy
25%
Hold
50%
Sell
25%
IFRX Earnings
-$0.65
-$0.43
-$0.22
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 5, Pre-Market